Your browser doesn't support javascript.
loading
Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou, Zheng; Hu, Taishan; Xu, Zhiheng; Lin, Zhaohu; Zhang, Zhisen; Feng, Teng; Zhu, Liangcheng; Rong, Yiping; Shen, Hong; Luk, John M; Zhang, Xiongwen; Qin, Ning.
Afiliação
  • Zhou Z; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China joe.zhou.jz2@roche.com.
  • Hu T; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Xu Z; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Lin Z; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Zhang Z; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Feng T; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Zhu L; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Rong Y; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Shen H; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Luk JM; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Zhang X; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
  • Qin N; *Discovery Technology, Medicinal Chemistry, and Discovery Oncology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China.
FASEB J ; 29(2): 724-32, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25384421
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Fatores de Transcrição / Proteínas Nucleares / Proteínas Serina-Treonina Quinases / Proteínas Adaptadoras de Transdução de Sinal / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: FASEB J Assunto da revista: BIOLOGIA / FISIOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Fatores de Transcrição / Proteínas Nucleares / Proteínas Serina-Treonina Quinases / Proteínas Adaptadoras de Transdução de Sinal / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: FASEB J Assunto da revista: BIOLOGIA / FISIOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China